Breast Cancer Clinical Trial

Comparison of Fulvestrant (FASLODEX™) 250 mg and 500 mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy.

Summary

The purpose of this study is to evaluate the efficacy of a new dose of 500 mg Fulvestrant with the standard dose of 250 mg in postmenopausal women with oestrogen receptor positive advanced breast cancer who have failed on a previous endocrine treatment.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Breast Cancer has continued to grow after having received treatment with an anti-estrogen hormonal treatment such as tamoxifen or an aromatase inhibitor
Requiring hormonal treatment
Postmenopausal women defined as a woman who has stopped having menstrual periods
Evidence of positive estrogen receptor hormone sensitivity
Written informed consent to participate in the trial

Exclusion Criteria:

Treatment with an investigational or non-approved drug within one month
An existing serious disease, illness, or condition that will prevent participation or compliance with study procedures
A history of allergies to any active or inactive ingredients of Faslodex (i.e. castor oil)
Treatment with more than one regimen of chemotherapy for advanced breast cancer
Treatment with more than one regimen of hormonal treatment for advanced breast cancer

Study is for people with:

Breast Cancer

Phase:

Phase 3

Estimated Enrollment:

736

Study ID:

NCT00099437

Recruitment Status:

Active, not recruiting

Sponsor:

AstraZeneca

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 98 Locations for this study

See Locations Near You

Research Site
Casa Grande Arizona, 85122, United States
Research Site
Fountain Valley California, 92708, United States
Research Site
New Britain Connecticut, 06052, United States
Research Site
Crystal River Florida, 34429, United States
Research Site
Fort Lauderdale Florida, 33308, United States
Research Site
Urbana Illinois, 61801, United States
Research Site
Rosedale Maryland, 21237, United States
Research Site
Detroit Michigan, 48202, United States
Research Site
Kansas City Missouri, 64131, United States
Research Site
Saint Louis Missouri, 63141, United States
Research Site
Voorhees New Jersey, 08043, United States
Research Site
Greenville North Carolina, 27858, United States
Research Site
Pasadena Texas, 77504, United States
Research Site
West Bend Wisconsin, 53095, United States
Research Site
Brasschaat , 2930, Belgium
Research Site
Brussels , 1070, Belgium
Research Site
Brussels , 1090, Belgium
Research Site
Edegem , 2650, Belgium
Research Site
Gent , 9000, Belgium
Research Site
Hasselt , 3500, Belgium
Research Site
Liège , 4000, Belgium
Research Site
Turnhout , 2300, Belgium
Research Site
Barretos , 14784, Brazil
Research Site
Londrina , 86010, Brazil
Research Site
Porto Alegre , 91350, Brazil
Research Site
Recife , 50670, Brazil
Research Site
Salvador , 40170, Brazil
Research Site
Sao Paulo , 04039, Brazil
Research Site
Antofagasta , , Chile
Research Site
Santiago , 83804, Chile
Research Site
Santiago , , Chile
Research Site
Bogota , , Colombia
Research Site
Cali , , Colombia
Research Site
Brno , 656 5, Czechia
Research Site
Ceske Budejovice , 370 8, Czechia
Research Site
Pardubice , 520 0, Czechia
Research Site
Praha 10 , 100 3, Czechia
Research Site
Praha 2 , 128 0, Czechia
Research Site
Praha 8 , 180 0, Czechia
Research Site
Tabor , 390 0, Czechia
Research Site
Nyíregyháza , 4400, Hungary
Research Site
Szombathely , 9700, Hungary
Research Site
Székesfehérvár , 8000, Hungary
Research Site
Ansari Nagar , 110 0, India
Research Site
Bhopal , 46200, India
Research Site
Hyderabad , 50008, India
Research Site
Jaipur , 30201, India
Research Site
Kolkata , 70005, India
Research Site
Manipal , 576 1, India
Research Site
Marg Jaipur , 30200, India
Research Site
Mumbai , 40001, India
Research Site
Pune , 41100, India
Research Site
Trivandrum , 2417, India
Research Site
Vellore , 63200, India
Research Site
Aviano , 33081, Italy
Research Site
Bergamo , 24128, Italy
Research Site
Carpi , 41012, Italy
Research Site
Genova , 16132, Italy
Research Site
Prato , 59100, Italy
Research Site
Reggio Emilia , 42100, Italy
Research Site
Varese , 21100, Italy
Research Site
Floriana , VLT 1, Malta
Research Site
Mexico City , 06720, Mexico
Research Site
Mexico , 01090, Mexico
Research Site
Mexico , 14140, Mexico
Research Site
Białystok , 15-02, Poland
Research Site
Poznań , 61-87, Poland
Research Site
Łódź , 90-55, Poland
Research Site
Ivanovo , 15304, Russian Federation
Research Site
Kazan, Tatarstan , 42002, Russian Federation
Research Site
Kazan, Tatarstan , 42011, Russian Federation
Research Site
Krasnodar , 35004, Russian Federation
Research Site
Lipetsk , 39800, Russian Federation
Research Site
Moscow , 10700, Russian Federation
Research Site
Moscow , 11547, Russian Federation
Research Site
Moscow , 12135, Russian Federation
Research Site
Moscow , 59401, Russian Federation
Research Site
Nizhniy Novgorod , 60308, Russian Federation
Research Site
Obninsk , 24902, Russian Federation
Research Site
Ryazan , 39004, Russian Federation
Research Site
St-Petersburg , 19775, Russian Federation
Research Site
St.-Petersburg , 19708, Russian Federation
Research Site
St.Petersburg , 19101, Russian Federation
Research Site
Yaroslavl , 15005, Russian Federation
Research Site
Bardejov , 08501, Slovakia
Research Site
Bratislava , 812 5, Slovakia
Research Site
Nitra , 949 0, Slovakia
Research Site
Trnava , 917 7, Slovakia
Research Site
A Coruña , 15006, Spain
Research Site
Madrid , 28040, Spain
Research Site
Malaga , 29010, Spain
Research Site
Oviedo , 33011, Spain
Research Site
Salamanca , 37007, Spain
Research Site
Sevilla , 41013, Spain
Research Site
Cherkasy , 18009, Ukraine
Research Site
Dnipro , 49102, Ukraine
Research Site
Donetsk , 83092, Ukraine
Research Site
Kyiv , 03022, Ukraine
Research Site
Lviv , 79031, Ukraine
Research Site
Sumy , 40022, Ukraine
Research Site
Ternopil , 46023, Ukraine
Research Site
Uzhhorod , 88000, Ukraine
Research Site
Caracas , , Venezuela

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Phase:

Phase 3

Estimated Enrollment:

736

Study ID:

NCT00099437

Recruitment Status:

Active, not recruiting

Sponsor:


AstraZeneca

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.